diabetes%20mellitus%20(pediatric)
DIABETES MELLITUS (PEDIATRIC)
Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both.
It can occur at any age and the earlier the onset, the more serious is the long-term damage, dysfunction and failure of various organs due to the chronic hyperglycemia with diabetes mellitus patients having <10 year in life span compared to non-DM patients.
Type 1 DM patients have complete insulin deficiency due to beta-cell destruction. It may be immune-mediated or idiopathic. More commonly occurs in children 7-15 year of age, but may occur at any age.
Type 2 DM patients have insulin resistance and relative insulin deficiency.
Neonatal DM is hyperglycemia that occurs in the first 6 months of life.

Introduction

  • Can occur at any age & the earlier the onset, the more serious the long-term damage, dysfunction, & failure of various organs due to the chronic hyperglycemia w/ diabetes mellitus (DM) patients having <10 years in life span compared to non-DM patients 

Definition

  • Diabetes mellitus (DM) is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion, insulin action, or both

Signs and Symptoms

Type 1 Diabetes Mellitus (DM)

  • Hyperglycemia, glycosuria, ketonemia & ketonuria w/ the following for several week:
    • Polyuria
    • Polydipsia
    • Polyphagia
    • Weight loss
  • May also present as severe dehydration, shock & diabetic ketoacidosis (DKA)

Type 2 Diabetes Mellitus (DM)

  • Overweight or obese
  • Glycosuria w/o ketonuria
    • Some may present w/ ketonuria
  • Absent or mild polyuria
  • May present w/ ketoacidosis associated w/ stress, infection or other illness
  • Acanthosis nigricans
  • Polycystic ovary syndrome (PCOS)
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
5 days ago
In patients with type 2 diabetes, obesity may be protective against vision-threatening diabetic retinopathy, a recent Korea study has shown.
Roshini Claire Anthony, 4 days ago

Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.

07 Jun 2019
Low-dose aspirin therapy does not confer significant benefits to elderly patients with hypertension, but treatment appears to increase the risk of haemorrhagic events, suggest a Japan study.
4 days ago
The use of opioids may have limited long-term efficacy in the management of chronic noncancer pain, reports a new study.